Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(27)
Filter by content year
(-)
2019
(27)
Filter by form group
Filter by category
Financial
(10)
All
(4)
Events
(4)
Filter by category
Search
News
BioNTech präsentiert auf der 38. Annual J.P. Morgan Healthcare Conference
News
BioNTech to Present at the 38th Annual J.P. Morgan Healthcare Conference
News
BioNTech schließt neue Kooperation zur Entwicklung von HIV- und Tuberkulose-Impfstoffen
News
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
News
BioNTech schließt überzeichnete Serie-B-Finanzierungsrunde über USD 325 Millionen ab, um seine individualisierte Krebsmedizin-Pipeline weiterzuentwickeln
News
BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
News
BioNTech und Genmab starten klinische Entwicklung von bi-spezifischem Duo-Body®-PD-L1x4-1BB mit Phase I/IIa Studie in soliden Tumoren
News
BioNTech and Genmab Initiate First-In-Human Phase I/IIa Trial of Bispecific Antibody DuoBody®-PD-L1x4-1BB in Solid Tumors
News
BioNTech erwirbt Antikörper-Assets von MabVax Therapeutics, um Portfolio zu erweitern
News
BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio
Pagination
Previous page
‹‹
Page 2
Next page
››